Vagus nerve stimulation in the treatment of pharmacoresistant depression

Neuroendocrinology Letters

Volumn 29, Issue SUPPL. 1, 2008, Pages 133-146

  Hotujac, Ljubomir ^a   Kuzman, Martina Rojnic ^a  

^a KBC Zagreb   (Croatia)

Author keywords

Depression; Neuromodulation; Treatment; Treatment resistant depression; Vagus nerve stimulation; VNS

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ANXIETY DISORDER; ARTICLE; CLINICAL EFFECTIVENESS; CLUSTER HEADACHE; DEPRESSION; EPILEPSY; ESSENTIAL TREMOR; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPOMANIA; IATROGENIC DISEASE; MAJOR DEPRESSION; MANIA; MEDICAL LITERATURE; MIGRAINE; PATIENT SAFETY; RISK BENEFIT ANALYSIS; SUICIDAL BEHAVIOR; THERAPY EFFECT; TREATMENT CONTRAINDICATION; VAGUS NERVE STIMULATION; WORK RESUMPTION;

DEPRESSIVE DISORDER; HUMANS; MENTAL DISORDERS; RISK FACTORS; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 63449088890     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Armitage R, Husain M, Hoffmann R, Rush J: The effects of vagus nerve stimulation (VNS) on sleep in depression. Actas de Fisiología, 2001; 7: 246
2. Bajbouj M, Gallinat J, Lang UE, Hellen F, Vesper J, Lisanby SH, Danker-Hopfe H, Neu P: Motor cortex excitability after vagus nerve stimulation in major depression. J. Clin. Psychopharmacol, 2007; 27: 156-9.
3. Ben-Menachem E, Manon-Espaillat R, Ristanovic R, Wilder BJ, Stefan H, Mirza W, Tarver WB, Wernicke JF: Vagus nerve stimulation for treatment of partial seizures: A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia, 1994; 35: 616-26.
4. Chai J: Medical device regulation in the United States and in the European Union: A comparative study. Food. Drug. Law. J, 2005; 55: 57-80.
5. Chavel SM, Westerveld M, Spencer S: Long-term outcome of vagus nerve stimulation for refractory partial epilepsy. Epilepsy. Behav, 2003; 4: 302-309.
6. Critchley HD, Lewis PA, Orth M, Josephs O, Deichmann R, Trimble MR, Dolan RJ: Vagus nerve stimulation for treatment-resistant depression: behavioural and neural effects on encoding negative material. Psychosom Med, 2007; 69: 17-22.
7. Diamond A, Kenney C, Jankovic J: Effect of vagal nerve stimulation in a case of Tourette's syndrome and complex partial epilepsy. Mov. Disord, 2006; 21: 1273-5.
8. Handforth A, Ondo WG, Tatter S, Mathern GW, Simpson RK Jr, Walker F, Sutton JP, Hubble JP, Jankovic J: Vagus nerve stimulation for essential tremor: a pilot efficacy and safety trial. Neurology, 2003; 61: 1401-5.
9. Dorr AE, Debonnel G: Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J. Pharmacol. Exp. Ther, 2006; 18: 890-8.
10. Duman RS, Heninger GR, Nestler EJ: A molecular and cellular theory of depression. Arch. Gen. Psychiatry, 1997; 54: 597-606.
11. Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE: Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy. Res, 2000; 42: 203-210.
12. Faris PL, Eckert ED, Kim SW, Meller WH, Pardo JV, Goodale RL, Hartman BK: Evidence for a vagal pathophysiology for bulimia nervosa and the accompanying depressive symptoms. J. Affect. Disord, 2006; 92: 79-90.
13. Fleischhacker WW, Meise U, Gunther V, Kurz M: Compliance with antipsychotic drug treatment: influence of side effects. Acta Psychiatr. Scand, 1994; 89 (suppl 382): 11-15.
14. Foley JO, DuBois F: Quantitative studies of the vagus nerve in the cat. I: The ratio of sensory and motor studies. J. Comp. Neurol, 1937; 67: 49-67.
15. George MS, Sackeim HA, Rush AJ et al. (2000). Vagus nerve stimulation: a new tool for brain research and therapy. Biol. Psychiatry, 2000; 47: 287-95.
16. George MS, Rush AJ, Sackeim HA, Marangell LB, Nahas Z, Husain MM, Lisanby S, BurtT, Goldman J, Ballenger JC: Vagus nerve stimulation (VNS): utility in neuropsychiatric disorders. Int. J. Neuropsychopharmacol, 2003; 6: 73-83.
17. George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM, Howland R, Kling MA, Moreno F, Rittberg B, Dunner D, Schwartz T, Carpenter L, Burke M, Ninan P, Goodnick P: A one-year comparison of Vagus Nerve Stimulation with Treatment as Usual for treatment-resistant depression. Biol. Psychiatry, 2005; 58: 364-373.
18. Grilo CM, Sanislow CA, Shea MT, Skodol AE, Stout RL, Gunderson JG, Yen S, Bender DS, Pagano ME, Zanarini MC, Morey LC, McGlashan TH: Two-year prospective naturalistic study of remission from major depressive disorder as a function of personality disorder comorbidity. J. Consult. Clin. Psychol, 2005; 73: 78-85.
19. Groves DA, Brown VJ: Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci. Biobehav. Rev, 2005; 29: 493-500.
20. Henry TR: Therapeutic mechanisms of vagus nerve stimulation. Neurology, 2002; 59(Suppl 4): S3-S14.
21. Hirshberg LM, Chiu S, Frazier JA: Emerging brain-based interventions for children and adolescents: overview and clinical perspective. Child Adolesc. Psychiatr. Clin. N. Am, 2005; 14: 1-19.
22. Hord ED, Evans MS, Mueed S, Adamolekun B, Naritoku DK: The effect of vagus nerve stimulation on migraines. J. Pain, 2003; 4: 530-534.
23. Husain MM, Stegman D, Trevino K: Pregnancy and delivery while receiving vagus nerve stimulation for the treatment of major depression: a case report. Ann. Gen. Psychiatry, 2005; 4: 16.
24. Kling MA, Loyd D, Sansbury N, Ke R, Murphy AZ: Effects of short term VNS therapy on Fos expression in rat brain nuclei. Poster at 58th Annual Scientific Convention of the Society of Biological Psychiatry. 2003, San Francisco, May 15-17.
25. Krahl SE, Senanayake SS, Handforth A: Destruction of peripheral C-fibers does not alter subsequent vagus nerve stimulation induced seizure suppression in rats. Epilepsia, 2001; 42: 586-589.
26. Lang UE, Bajbouj M, Gallinat J, Hellweg R: Brain-derived neurotrophicfactor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation. Psychopharmacology (Berl), 2006; 187: 56-9.
27. Marangell LB, Rush AJ, George MS, Sackeim HA, Johnson CR, Husain MM, Nahas Z, Lisanby SH: Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol. Psychiatry, 2002; 51: 280-7.
28. Mauskop A: Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches. Cephalgia, 2005; 25: 82-6.
29. Nahas Z, Marangell LB, Husain MM, Rush AJ, Sackeim HA, Lisanby SH, Martinez JM, George MS: Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J. Clin. Psychiatry, 2005; 66: 1097-1104.
30. Nemeroff CB, Mayberg HS, Krahl SE, McNamara J, Frazer A, Henry TR, George MS, Charney DS, Brannan SK: VNS therapy in treatment resistant depression: Clinical evidence and putative neurobiological mechanisms neuropsychopharmacology, 2006; 31: 1345-1355.
31. O'Reardon JP, Cristancho P, Peshek AD: Vagus Nerve Stimulation (VNS) and treatment of depression: to the brainstem and beyond. Psychiatry, 2006; 5: 54-63.
32. Pardo JV, Sheikh SA, Kuskowski MA, Surerus-Johnson C, Hagen MC, Lee JT, Rittberg BR, Adson DE: Weight loss during chronic, cervical vagus nerve stimulation in depressed patients with obesity: an observation. Int. J. Obes (Lond), 2007; 31: 1756-1759.
33. Parker APJ, Polkey CE, Binnie CD, Madigan C, Ferrie CD, Robinson RO: Vagal Nerve Stimulation in Epileptic Encephalopathies. Pediatrics, 1999; 103: 778-782.
34. Patwardhan R, Cardenas R, Myers D, Ware P, Nanda A: Left vagus nerve stimulation for depression: first implantation case post-FDA approval and review of the literature. J. La. State Med. Soc, 2007; 159: 38-41.
35. Percudani M, Barbui C, Fortino I, Petrovich L: Antidepressant drug use in Lombardy, Italy: a population-based study. J. Affect. Disord, 2004; 83: 169-175.
36. Rudolph R: Food and Drug Administration Neurogical Devices panel Web site, 2005. www.fda.gov/ohrms/dockets.ac/04/briefing/ 4047b101Clinical%20Executive%20Sumary-FINAL.pdf
37. Rush AJ, George MS, Sackeim HA, Marangell LB, Husain MM, Giller C, Nahas Z, Haines S, Simpson Jr RK, Goodman R: Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatr, 2000; 47: 276-286.
38. Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, Howland R, Kling MA, Rittberg BR, Burke WJ, Rapaport MH, Zajecka J, Nierenberg AA, Husain MM, Ginsberg D, Cooke RG: Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol. Psychiatr, 2005a; 58: 347-354.
39. Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, Lavori P, Howland R, Kling MA, Rittberg B, Carpenter L, Ninan P, Moreno F, Schwartz T, Conway C, Burke M, Barry JJ: Vagus nerve stimulation for treatment-resistant depression: a naturalistic study. Biol. Psychiatr, 2005b; 58: 355-363.
40. Sackeim HA:. The definition and meaning of treatment resistant depression. J. Clin. Psychiatry, 2001; 62(Suppl 16): 10-17.
41. Sackeim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z, Johnson CR,Seidman S, Giller C, Haines S, Simpson RK Jr, Goodman RR: Vagus Nerve Stimulation (VNS™) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology, 2001a; 25: 713-728.
42. Sackeim HA, Keilp JG, Rush AJ, George MS, Marangell LB, Dormer JS, Burt T, Lisanby SH, Husain M, Cullum CM, Oliver N, Zboyan H: The effects of vagus nerve stimulation on cognitive performance in patients with treatment resistant depression. Neuropsychiary Neuropsychol. Behav. Neurol, 2001b; 14: 53-62.
43. Sackeim HA, Brannan SK, Rush AJ, George MS, Marangell LA, Allen J: Durability of antidepressant response to vagus nerve stimulation (VNS™). Int. J. Neuropsychopharmacol, 2007; doi: 10.1017/ S1461145706007425, p1-10.
44. Sadock BJ, Sadock VA. Synopsis of psychiatry. Behavioural Sciences/ Clinical Psychiatry. 9th ed. Philadelphia: Lippincott Williams & Wiikins, 2003.
45. Saneto RP, Sotero de Menezes MA, Ojemann JG, Bournival BD, Murphy PJ, Cook WB, Avellino AM, Ellenbogen RG: Vagus nerve stimulation for intractable seizures in children. Pediatr. Neurol, 2006; 35: 323-326.
46. Sjögren MJ, Hellstrom PT, Jonsson MA, Runnerstam M, Silander HC, Ben-Menachem E: Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study. J. Clin. Psychiatry, 2002; 63: 972-980.
47. Ustün TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ: Global burden of depressive disorders in the year 2000. Br. J. Psychiatry, 2004; 184: 386-392.
48. Uthman BM, Reichl AM, Dean JC, Eisenschenk S, Gilmore R, Reid S et al (2004). Effectiveness of vagus nerve stimulation in epilepsy patients: a 12-year observation. Neurology. 63: 1124-1126 (OUT)
49. Christmas DMB, Curran S, Matthews K, Eljamel MS (2006). Neurosurgery for mental disorder, vagus nerve stimulation and deep brain stimulation. Psychiatry. 5: 211 -216. (OUT)
50. MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT et al (2003). Course of illness, hippocampal function, and hippocampal volume in major depression. PNAS. 100: 1387-1392 (OUT)
51. Murray C, Lopez A (1996). The Global burden of disease: A comprehensive assessment of mortality and disability from disease, injuries and riskfactors in 1990 and projected to 2020. Cambridge, MA: Harcourt University Press (OUT).